Leading VCs Look to Medtech Insight's 'Investment In Innovation' Conference for Maximum Exposure to High-Caliber Early-Stage Medical Technology Companies.

NEWPORT BEACH, Calif. -- Oct. 21-22, 2004, The Westin Copley Place Hotel, Boston

Medtech Insight, a division of Windhover Information Inc. and a leading provider of business information on new trends, technologies and emerging companies in the medical device industry, has announced that over 40 emerging medical technology companies are already confirmed to present at its "Investment In Innovation (In3): A Preview of Early-Stage Medical Technology Companies" conference, being held on Oct. 21-22, 2004 at The Westin Copley Place Hotel in Boston. The company will host a total of approximately 55 early-stage medical technology companies in all, most presenting for the first time at an In3 event, as well as 400 senior executives from the leading healthcare investment firms and medical device companies. See the Medtech Insight Web site at http://www.medtechinsight.com/in3-12.html for conference details and registration information.

Medtech Insight is a leading provider of business information on emerging technologies, companies and market opportunities in the medical device industry. The company's In3 conferences bring together small emerging medical technology companies, venture capitalists, investment bankers, and corporate business development executives, for funding, acquisition, and/or strategic partnership opportunities. Company executives have announced that the Boston event will draw the largest audience of dealmakers in the medical technology industry to date.

Leading investors have given the "Investment In Innovation" conferences rave reviews as a one-of-a-kind venue for accessing high-quality companies and technologies, in a well-organized, and time- and cost-effective environment. According to Chris Wagner, director of KPMG Corporate Finance (Atlanta): "Medtech Insight's conferences have filled a real void for the investment community by providing a first-class forum for early-stage companies to get in front of VCs and corporate investors. This is a great opportunity to evaluate a broad array of innovative medical technology companies at one event." Chris Stenzel, senior vice president of Kaiser Permanente Ventures in Oakland, Calif, said: "Medtech Insight conferences attract high-caliber companies, so it gives me a rare chance to see dozens of potentially outstanding investment opportunities in just a day and a half. I know I'll be making maximum good use of my time by attending a Medtech Insight meeting."

Presenting companies confirmed thus far for the Boston event (more being added; see www.medtechinsight.com for an updated listing) include: Access Bio, Access CardioSystems, Acologix, Acta Vascular Systems, Adiana, Affinergy, Alveolus, Applied Spine Technologies, Argentum, BioCare Systems, BioniCare Medical Technologies, Biowave, Bone Solutions, Cardiac Assist, Cardio-Optics, Cerdak, Cordeus, CoreValve, GARRETTtechnologies, GlucoLight, Heart Assist Technologies, HemaMetrics, Keimar, Kinetic Concepts, LifeAssays, Matryx Group, Mazor Surgical Technologies, MDMI Technologies, MedSignals, MicroMRI, MINRAD, MiTiHeart, Monteris Medical, MRIC Drug Delivery Systems, Nervonix, NMT Medical, NovoSci, OsteoResorb, Polymerix, RX-SPINE, SafetyNet, and ZARS. The Boston In3 conference will also feature presentations by a number of medtech industry thought leaders, and an informative and dynamic industry panel discussion.

In3 Boston is a must-attend event for anyone interested in emerging medical technology. To register to attend, call Medtech Insight at 949-219-0150, or 888-290-2225 toll-free in the United States, or register on the Medtech Insight Web site, at http://www.medtechinsight.com/in3-12.html. To read what industry experts think of Medtech Insight's In3 events, please visit http://www.medtechinsight.com/in3success.html. Through July 31 only, attendees registering for this event can save $200 off the $1,395 registration rate.

Co-sponsors for the Boston In3 event include: AdvaMed, Battelle, Business Wire, Dorsey & Whitney LLP, Medmarc and The Hartford, The MedTech Group, PPD Medical Device, Reimbursement Principles, Ronald Trahan Associates Inc., and Underwriters Laboratories.

ABOUT MEDTECH INSIGHT

Recently acquired by Windhover Information Inc., publisher of IN VIVO: The Business & Medicine Report, Start-UP: Windhover's Review of Emerging Technologies, and IN VIVO EuropeRx, Medtech Insight is a leading provider of business information for the medical technology marketplace. The company publishes the "medtech insight" newsletter, a monthly publication covering the latest trends and innovations in the medical technology industry. The company also publishes analyses of medtech markets through its Market & Technology Reports group, offers custom consulting and market research, and holds medical technology investment conferences several times a year.

To register for the Boston conference or for more information on the company's upcoming "IN SPINE: Strategic Partnering and Investing in Spine" conference, being held in Dallas on Nov. 11, 2004, please call 949-219-0150 or 888-290-2225 toll-free in the United States, fax [phone], e-mail [e-mail], or visit http://www.medtechinsight.com/in3-12.html. Visit the company's Web site at www.medtechinsight.com to read more about In3 conferences, view tables of contents for published and upcoming reports, and download a sample issue of the "medtech insight" newsletter. Windhover Information Inc. (www.windhover.com), based in Norwalk, Conn., is a leading provider of information products and services to senior executives in the pharmaceutical, biotechnology, and medical device industries.